Mechanism of vascular smooth muscle relaxation by estrogen in depolarized rat and mouse aorta: Role of nuclear estrogen receptor and Ca2+ uptake

Circulation Research

Volumn 81, Issue 2, 1997, Pages 242-248

  Freay, Ana D ^a   Curtis, Sylvia W ^b   Korach, Kenneth S ^b   Rubanyi, Gabor M ^a  

^a BAYER AG   (Germany)

^b NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

17 estradiol; 17 estradiol; Diethylstilbestrol; Estrone; Mice, estrogen receptor deficient

Indexed keywords

17ALPHA ESTRADIOL; CALCIUM; DIETHYLSTILBESTROL; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR; ESTRONE;

ANIMAL TISSUE; AORTA; ARTICLE; CALCIUM TRANSPORT; CONTROLLED STUDY; FEMALE; HEART PROTECTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; VASCULAR SMOOTH MUSCLE; VASODILATATION;

EID: 0030822764     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.81.2.242     Document Type: Article

References (48)

1. Bush TL, Millet VT. Effects, of pharmacologic agents used during menopause: impact on lipids and lipoproteins In: Mishell DR Jr, ed. Menopause: Physiology and Pharmacology. Chicago, III: Chicago Year Book Medical Publishers; 1987:187-208.
2. Stampfer MJ, Colditz GA, Willett WC, Manson JE, Rosner B, Speizer FE, Hennekens CH. Postmenopausal estrogen therapy and cardiovascular disease. N Engl J Med. 1991;325:756-762.
3. Van-Der-Mooren MJ, Demacker PN, Thomas CM, Rolland R. Beneficial effects on serum lipoproteins by 17 beta-oestradiol-dydrogesterone therapy in postmenopausal women: a prospective study. Eur J Obstet Gynecol Reprod Biol. 1992;47:153-160.
4. Clarkson TB, Shively CA, Morgan TM, Koritnik DR, Adams MR, Kaplan JR. Oral contraceptives and coronary artery atherosclerosis of cynomologus monkeys. Am J Obstet Gynecol. 1990;75:217-222.
5. Adams MR, Kaplan JR, Manuck SB, Koritnik DR, Parks JS, Wolfe MS, Clarkson TB. Inhibition of coronary artery atherosclerosis by 17β-estradiol in ovariectomized monkeys: lack of an effect of added progesterone. Arteriosclerosis. 1990;10:1051-1057.
6. Stevenson JC, Crook D, Godsland IF, Collins P, Whitehead MI. Hormone rcplacement therapy and the cardiovascular system: nonlipid effects. Drug. 1994;47(suppl 2):35-41.
7. Colburn P, Buonassisi V. Estrogen-binding sites in endothelial cell cultures. Science. 1978;201:817-819.
8. Horwitz K, Horwitz CD. Canine vascular tissues are targets for androgens, estrogens, progestins and glucocorticoids. J Clin lnvest. 1982;69:750-758.
9. Lin AL, McGill HC, Shain SA. Hormone receptors of the baboon cardiovascular system. Circ Res. 1982;50:610-616.
10. Lin AL, Gonzalez R Jr, Carey KD, Shain SA. Estradiool-17 beta affects estrogen receptor distribution and elevates progesterone receptor content in baboon aorta. Arteriosclerosis. 1986;6:495-504.
11. Perrot-Applanat M, Groyer-Picard MT, Garcia E, Lorenzo F, Milgrom E. Immunochemical demonstration of estrogen and progesterone receptors in muscle cells of uterine arteries in rabbits and humans. Endocrinology. 1988;123:1511-1519.
12. Gisclard V, Miller VM, Vanhoutte PM. Effect of 17β-estradiol on endothelium-dependent responses in the rabbit. J Pharmacol Exp Ther. 1988;244:9-22.
13. Williams JK, Adams MR, Klopfenstein HS. Estrogen modulates responses of atherosclerotic coronary arteries. Circulation. 1990;81:1680-1687.
14. Hayashi T, Fukuto JM, Ignarro LJ, Chaudhuri G. Basal release of nitric oxide from aortic rings is greater in female rabbits than in male rabbits: implications for atherosclerosis. Proc Natl Acad Sci USA. 1992;89:11259-11263.
15. Kauser K, Rubanyi GM. Gender difference in bioassayable endotheliuin-derived nitric oxide from isolated rat aortae. Am J Physiol. 1994;267:H2311-H2317.
16. Kauser K, Rubanyi G. Gender difference in endothelial dysfunction in the aorta of spontaneously hypertensive rats. Hypertension. 1995;25:517-523.
17. Reis SE, Gloth ST, Blumenthal RS, Resar J, Zacur HA, Gerstenblith G, Brinker JA. Ethinyl estradiol acutely attenuates abnormal coronary vasomolor responses to acetylcholine in postmenopausal women. Circulation. 1994;89:52-60.
18. Weiner CP, Lizasoain I, Baylis SA, Knowles RG, Charles IG, Moncada S, Induction of calcium-dependent nitric oxide synthases by sex hormones. Proc Natl Acad Sci USA. 1994;91:5212-5216.
19. Jiang C, Sarrel PM, Lindsay DC, Poole-Wilson PA, Collins P. Endothelium-independent relaxation of rabbit coronary artery by 17β-estradiol in vitro. Br J Pharmacol. 1991;104:1033-1037.
20. Jiang C, Sarrel PM, Poole-Wilson PA, Collins P. Acute effect of 17β-estradiol on rabbit coronary artery contractile responses to endothelin-l. Am J Physiol. 1992;263:H271-H275.
21. Collins P, Rosano GM, Jiang C, Lindsay D, Sarrel PM, Poole-Wilson PA. Cardiovascular protection by estrogen: a calcium antagonist effect? Lancet. 1993;341:1264-1265.
22. Salas E, Lopez MG, Villarroya M, Sanchez-Garcia P, De-Pascual R, Dixon WR, Garcia AG. Endothelium-independent relaxation by 17α-eslradiol of pig coronary arteries. Eur J Pharmacol. 1994;258:47-55.
23. Schumacher M. Rapid membrane effects of steroid hormones: an emerging concept in neuroendocrinology. Trends Neurosci. 1990;13:359-362.
24. McEwen BS. Non-genomic and genomic effects of steroids on neural activity. Trends Pharmacol Sci. 1991;12:141-147.
25. Nakao J, Chang WC, Murota SI, Orimo H. Estradiol-binding sites in rat aortic smooth muscle cells in culture. Atherosclerosis. 1981;38:75-80.
26. Orimo A, Inoue S, Ikegami A, Hosoi T, Akishita M, Ouchi Y, Muramatsu M, Orimo H. Vascular smooth muscle cells as target for estrogen, Biochem Biophys Res Commun. 1993;195:730-736.
27. Gutierrez M, Martinez V, Cantabrana B, Hidalgo A. Genomic and non-genomic effects of steroidal drugs on smooth muscle contraction in vitro. Life Sci. 1994;55:437-443.
28. Beato M. Gene regulation by steroid hormones. Cell. 1989;56:335-344.
29. Lubahn DB, Moyer JS, Golding TS, Course JF, Korach KS, Smithies O. Alteration of reproductive function but not prenatal sexual development after insertional disruption of the mouse estrogen receptor gene. Proc Natl Acad Sci USA. 1993;90:11162-11166.
30. Korach KS. Estrogen action in the mouse uterus: characterization of the cytosol and nuclear receptor system. Endocrinology. 1979;104:1324-1332.
31. Golding TS, Korach KS. Nuclear estrogen receptor molecular heterogeneity in the mouse uterus. Proc Natl Acad Sci USA 1988;85:69-73.
32. Couse JF, Curtis SW, Washburn TF, Lindzey J, Golding TS, Lubahn DB, Smithies O, Korach KS. Analysis of transcription and estrogen insensitivity in the female mouse after targeted disruption of the estrogen receptor gene. Mol Endocrinol. 1995;9:1441-1454.
33. 45Ca uptake in isolated rat aorta: effects of washing in ice cold solutions. Pflugers Arch. 1989;415:579-583.
34. 2+ release induced by thromboxane A2 in porcine cornary artery. Circulation. 1995;91:2619-2626.
35. Raddino R, Manca C, Poli E, Bolognesi R, Visioli O. Effects of 17 beta-estradiol on the isolated rabbit heart. Arch Int Pharmacodyn Ther. 1986;281:57-65.
36. Eckstein N, Nadler E, Barnea O, Shavit G, Ayalon D. Acute effects of 17βestradiol on the rat heart. Am J Obstet gynecol. 1994;171:844-848.
37. Shan J, Resnich LM, Liu QY, Wu XC, Barbagallo M, Pang PK, Vascular effects of 17β-estradiol in male Sprague-Dawley rats. Am J Physiol. 1994;266:H967-H973.
38. Harder DR, Coulson PB. Estrogen receptors and effects of etsrogen on membrane electrical properties of coronary vascular smooth muscle. J Cell Physiol. 1979;100:375-382.
39. Kishi Y, Numano F. A study of the mechanism of estrogen as an antiatherosclerotic: the inhibitory effect of estrogen on A23187-induced contraction of the aortic wall. Mech Ageing Dev. 1982;18:115-123
40. Chang WC, Nakao J, Orimo H, Murota S. Stimulation of prostacyclin biosynthetic activity by estradiol in rat aortic smooth muscle cells in culture. Biochem Biophys Acta. 1980;619:107-118.
41. Van Buren GA, Yang DS, Clark KE. Estrogen-induced uterine vasodilation is antagonized by L-nitroarginine methyl ester, an inhibitor of nitric oxide synthesis. Am J Obstet Gynecol. 1992;19:828-833.
42. Rubanyi GM, Freay AD, Kauser K, Sukovich D, Burton G, Lubahn D, Course JF, Curtis SW, Korach KS. Vascular estrogen receptors and endothelium-derived nitric oxide in mouse aorta. J Clin Invest. 1997;99:2429-2438.
43. Kuiper GGJM, Enmark E, Pelto-Huikko M, Nilsson S, Gustafsson J-Å. Cloning of a novel estrogen receptor expressed in rat prostate and ovary. Proc Natl Acad Sci U S A. 1996;93:5925-5930.
44. Kuiper GGJM, Nilsson S, Gustafsson J-Å. Cloning, expression and funcuon of a novel estrogen receptor. In: Rubanyi GM, ed. Estrogen and the Vessel Wall. London, England: Harwood Academic Publisher. In press.
45. Pietras R, Szego C. Specific binding Sites for oestrogen at the outer surface of isolated endometrial cells. Nature. 1977;265:69-72.
46. Pietras RJ, Szego CM. Estrogen receptors in uterine plasma membrane. J Steroid Biochem. 1979;11:1471-1483.
47. Batra S. Interaction of antiestrogens with binding sites for muscarinic cholinergic drugs and calcium channel blockers in cell membranes. Cancer Chemother Pharmacol. 1990;26:310-312.
48. Mueck AO, Seeger H, Lippert JH. Calcium antagonistic effect of natural and synthetic estrogens: investigations on a nongenomic mechanism of direct vascular action. Int J Clin Pharmacol Ther. 1996;34:424-426.